Leucocin A (18-35)[E3R;N14,17R]
General Information
DRACP ID DRACP00657
Peptide Name Leucocin A (18-35)[E3R;N14,17R]
Sequence WGRAFSAGVHRLARGGRG
Sequence Length 18
UniProt ID Not available
PubChem CID Not available
Origin Synthetic
Type Synthetic peptide
Classification
Active ACP
Activity Information
Cell Line | Disease | Cancer Classified | Activity | Assay | Testing Time | Literature |
---|---|---|---|---|---|---|
HepG2 | Hepatoblastoma | Blastoma | IC50=64µM | MTT assay | 24h | 1 |
Hemolytic Activity Human erythrocytes:10% Hemolysis>67.01µM
Normal (non-cancerous) Cytotoxicity Not available
Target Not available
Affinity Not available
Mechanism Not available
Nature Anticancer; Antibacterial; Antifungal
Structure Information
Helicity Not available
Linear/Cyclic Linear
Disulfide/Other Bond Not available
N-terminal Modification Free
C-terminal Modification Amidation
Other Modification None
Chiral L
Physicochemical Information
Formula C83H131N33O20
Absent amino acids CDEIKMNPQTY
Common amino acids G
Mass 221457
Pl 12.98
Basic residues 5
Acidic residues 0
Hydrophobic residues 7
Net charge 5
Boman Index -4334
Hydrophobicity -48.33
Aliphatic Index 54.44
Half Life
Mammalian: 2.8 hour
Yeast: 3 min
E.coli: 2 min
Extinction Coefficient cystines 5500
Absorbance 280nm 323.53
Polar residues 6
Amino acid distribution
Literature Information
Literature 1
Pubmed ID 28002968
Title Insights into the Antimicrobial Activity and Cytotoxicity of Engineered α-Helical Peptide Amphiphiles
Doi 10.1021/acs.jmedchem.6b00922
Year 2016
Patent
Patent ID Not available
Patent Title Not available
Other Iinformation Not available
Other Published ID Not available